11
Concurrent Management of StUD and ADHD
26. For patients with co-occurring StUD and ADHD, clinicians should
address ADHD symptoms as part of the treatment of StUD (L-S).
Clinicians should consider:
a. prescribing psychostimulant medications to manage ADHD when the benefits
of the medication outweigh the risks (L-S),
b. prescribing non-stimulant medications to manage ADHD when the benefits of
psychostimulant medications do not outweigh the risks (L-S), and
c. behavioral approaches (L-S).
27. When prescribing psychostimulant medications to a patient with
co-occurring StUD and ADHD, clinicians should consider:
a. using extended-release formulations (CC-S); and
b. maintaining a level of monitoring commensurate with the risk profile for the
given medication and patient—monitoring may include pill counts, drug
testing, more frequent clinical contact, and more frequent PDMP checks
(CC-C).
28. For adolescent and young adult patients with co-occurring StUD and
ADHD, clinicians should additionally consider:
a. arranging for a parent, health professional (eg, trained school nurse), or other
trusted adult to directly observe administration of the medication, especially if
using a short-acting formulation (CC-S); and
b. counseling families on the importance of safely storing and restricting access to
controlled medications (CC-C).
